Literature DB >> 2817363

Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue.

D S Millington1, D L Norwood, N Kodo, C R Roe, F Inoue.   

Abstract

Using a precursor-ion scan function on a triple quadrupole mass spectrometer, acylcarnitines were detected in the target matrices at or below concentrations of 1 nmol per gram by fast atom bombardment mass spectrometry. Acylcarnitine profiles from patients with known metabolic disorders were consistent with previously acquired data. Putative acylcarnitine signals were confirmed in one case by administration of stable isotope-labeled carnitine, which equilibrated rapidly with the endogenous pool. The addition of a continuous flow system enabled rapid sequential analysis without operator intervention, indicating the potential for automation of the analytical procedure. Incorporation of a micro-LC column enabled on-line liquid chromatographic/mass spectrometric analysis of selected patient samples. Large-scale screening and quantitative analysis of urine or blood for diagnostic acylcarnitines are now practicable.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817363     DOI: 10.1016/0003-2697(89)90441-7

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  33 in total

1.  Newborn screening.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2010-05

2.  Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism.

Authors:  D S Millington; N Kodo; D L Norwood; C R Roe
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 3.  Potential Uses and Inherent Challenges of Using Genome-Scale Sequencing to Augment Current Newborn Screening.

Authors:  Jonathan S Berg; Cynthia M Powell
Journal:  Cold Spring Harb Perspect Med       Date:  2015-10-05       Impact factor: 6.915

4.  Principles and applications of liquid chromatography-mass spectrometry in clinical biochemistry.

Authors:  James J Pitt
Journal:  Clin Biochem Rev       Date:  2009-02

5.  Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation.

Authors:  D M Kurtz; P Rinaldo; W J Rhead; L Tian; D S Millington; J Vockley; D A Hamm; A E Brix; J R Lindsey; C A Pinkert; W E O'Brien; P A Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

6.  Identification of a new mutation in medium-chain acyl-CoA dehydrogenase (MCAD) deficiency.

Authors:  J H Ding; B Z Yang; Y Bao; C R Roe; Y T Chen
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

Review 7.  New developments in neonatal screening.

Authors:  K Bartlett; S J Eaton; M Pourfarzam
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-09       Impact factor: 5.747

8.  Glycine and L-carnitine therapy in 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  S L Rutledge; G T Berry; C A Stanley; J L van Hove; D Millington
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

9.  Acylcarnitine profile in tissues and body fluids of biotin-deficient rats with and without L-carnitine supplementation.

Authors:  Y Shigematsu; I L Bykov; Y Y Liu; A Nakai; Y Kikawa; M Sudo; M Fujioka
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

10.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.

Authors:  J L Van Hove; W Zhang; S G Kahler; C R Roe; Y T Chen; N Terada; D H Chace; A K Iafolla; J H Ding; D S Millington
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.